TQB3909 Tablets in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (MCL)

RECRUITING

Peking University Third Hospital, Beijing

RECRUITING

The Second Hospital of Dalian Medical University, Dalian

RECRUITING

Jilin Cancer Hospital, Changchun

RECRUITING

The First Hospital of Jilin University, Changchun

RECRUITING

The Second Affiliated Hospital of Harbin Medical University, Harbin

RECRUITING

Affiliated Cancer Hospital of Harbin Medical University, Harbin

RECRUITING

Shanghai Huashan Hospital, Shanghai

RECRUITING

Tongji hospital of Tongji University, Shanghai

RECRUITING

The Second Affiliated Hospital of Soochow University, Suzhou

RECRUITING

The First Affiliated Hospital Of Soochow University, Suzhou

RECRUITING

The First Affiliated Hospital of Ningbo University, Ningbo

RECRUITING

The Affiliated Hospital of Xuzhou Medical University, Nanjing

RECRUITING

Binzhou Medical University Hospital, Binzhou

RECRUITING

Linyi People's Hospital, Linyi

RECRUITING

Tianjin Medical University Cancer Institute and Hospital, Tianjin

RECRUITING

Institute of Dematology & Blood diseases Hospital, Tianjin

RECRUITING

The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou

RECRUITING

The First Affiliated Hospital of Xiamen University, Xiamen

RECRUITING

Chongqing University Hospital, Chongqing

RECRUITING

Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology, Wuhan

RECRUITING

Henan Cancer Hospital, Zhengzhou

RECRUITING

Guangxi Medical University Cancer Hospital, Nanning

RECRUITING

Jinzhou Central Hospital, Wuxi

RECRUITING

The Affiliated Hospital of Southwest Medical University, Luzhou

RECRUITING

Gansu Provincial Cancer Hospital, Lanzhou

RECRUITING

Xinjiang Uygur Autonomous Region People's Hospital, Ürümqi

RECRUITING

The Affiliated Hospital of Chengde Medical College, Chengde

RECRUITING

Heping Hospital Affiliated to Changzhi Medical College, Changzhi